This article is 3 years old
NPRA: Lian Hua pills licensed for ‘heatiness, phlegm and cough’, not Covid-19
The WHP Modified Lian Hua Qing Wen Capsule, recently licensed by the National Pharmaceuticals Regulatory Agency (NPRA), was not registered as a Covid-19 treatment, the agency said.
When asked if the tablets were licensed for Covid-19 treatment, NPRA said the tablets were registered as “traditionally used to reduce body heatiness, relieve cough and phlegm”...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable